What's Happening with CVS
CVS Health Corp (CVS) is scheduled to report Quarter 3 numbers before the market open on August 4. Analysts forecast earnings of $0.81 per share for the quarter. During the same period last year the company earned $0.79, and the stock is up 20.6% on the year.
Technical Analysis
CVS was recently trading at $82.34 down $8.27 from its 12-month high and $26.98 above its 12-month low. InvestorsObserver gives CVS a 63 long-term technical score and a 46 short-term technical score. The stock has recent support above $79.74 and recent resistance below $89.2. Of the 17 analysts who cover the stock 10 rate it Strong Buy, 1 rate it Buy, 6 rate it Hold, 0 rate it Sell, and 0 rate it Strong Sell, CVS gets an overall score of 59 from InvestorsObserver.
Analysts' Thoughts
CVS has shown annual earnings growth of 10.62% over the last five years, and looking ahead analysts expect the company to grow profits 4.01% per annum the next five years. Last quarter the company posted better than expected EPS and this quarter the street expects $1.93 EPS. CVS is currently trading at $82.34 with an average price target of $94.90.